fda glp-1 warning letters october 2025 September 8, 2025: launches an import alert listing safe manufacturers – Partnership for Safe Medicines FDA Sends Warning Letters to

Online GLP-1 providers are licensed telehealth companies that help people get prescription weight loss medicine like semaglutide and tirzepatide from home

Circulation 142 (12), 12051218

Your medical history: Heart disease, kidney function, gallbladder issues, pancreatitis history, GI motility disorders, or thyroid cancer risk

10.3390/toxics13070594 14 EngstrmA.WintzellV.MelbyeM.SvanstrmH.EliassonB.GudbjrnsdottirS.et al (2024)

Patients using tirzepatide for legitimate medical purposes should not be concerned about false-positive results on employment or pre-procedural drug screens

However, gastrointestinal effects of these medicationsparticularly delayed gastric emptyingcould theoretically affect levothyroxine absorption if medications are taken simultaneously